Products:Epigenetics and Nuclear Signaling >> Transcription >> Polymerase associated factors >> Pol II Transcription
|
ab12793 |
RNA polymerase II CTD repeat YSPTSPS peptide - phospho S2 (ab12793) |
|
ab12793 |
RNA polymerase II CTD repeat YSPTSPS peptide - phospho S2 (ab12793) |
|
ab17564 |
|
|
ab17564 |
|
|
ab18488 |
RNA polymerase II CTD repeat YSPTSPS peptide - phospho S5 (ab18488) |
|
ab18488 |
RNA polymerase II CTD repeat YSPTSPS peptide - phospho S5 (ab18488) |
|
ab51501 |
|
|
ab52579 |
|
ab46666 |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »This product is covered by the Abpromise guarantee. Our scientific support team are available to answer any questions or queries - fill out an inquiry form for ab26721 for help.
Alternatively, you can search the previous enquiries about this product to see if your query has already been answered.
|
|||||||||
|
|||||||||
I attended your ChIP webinar last February.I am currently optimizing a ChIP-seq protocol with my cells (murine primary cells), with an antibody against Pol-II (product ab817). Before going on with the sequencing part, I would like to make sure that my immunoprecipitation worked well. As you suggested in your Webinar, I am looking for positive and negative control loci that I will test first by qPCR. Would you have any suggestions for negative control regions for Pol-II binding ? Have you ever used telomeric or intergenic regions for example, or would you rather recommend non-expressed genes in the tissue under study ? I also saw in some cases people using negative ascites as control. What is that for ? |
|||||||||
ANSWER: |
Thank you for contacting us. |
||||||||
|
|||||||||
Dear Abcam Abreviews Team |
|||||||||
ANSWER: |
Thank you for sending your western blot image again. I have included it in your Abreview which is now published on our website. |
||||||||
|
|||||||||
former lots worked well in ChIP this lot GR 33496-1 gives not good results samples: human prostate RT-PCR enrichment used to be 4 CT previously now no enrichment seen (with or withour treatment), done 2-3 times no change in protocol or samples Ab: 1 ug per reaction |
|||||||||
ANSWER: |
Thank you for confirming these details and for your cooperation. The details provided enable us to closely monitor the quality of our products.
I am sorry this product did not perform as stated on the datasheet and for the inconvenience this has caused. As requested, I have issued a free of charge replacement with the order number xxx. The estimated delivery date is xxxx.
To check the status of the order please contact our Customer Service team and reference this number.
Please note that this free of charge replacement vial is also covered by our Abpromise guarantee. Should you still be experiencing difficulties, or if you have any further questions, please do not hesitate to let us know.
I wish you the best of luck with your research. |
||||||||
|
|||||||||
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Chromatin was prepared from Hela cells according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10min. The ChIP was performed with 25µg of chromatin, 5µg of ab26721 (blue), and 20µl of Protein A/G sepharose beads. No antibody was added to the beads control (yellow). The immunoprecipitated DNA was quantified on the inactive AFM and F8 promoters, the GAPDH promoter (active) and over the g-Actin gene (active). Schematic diagram of the g-Actin gene is shown on the top of the figure. Black boxes represent exons and thin lines represent introns. PCR products are depicted as bars under the gene.
ab26721 (1/200) staining RNA polymerase II in assyncchonous HeLa cells (green). cells were fixed in paraformaldehyde, permeabilised in 0.5% Triton X100 and counterstained with DAPI in order to highlight the nucleus (red). For further experimental details please refer to Abreview.
Image courtesy of an abreview submitted by Dr. Kirk McManus, Univ. of Manitoba/Cancer Care MICB, Canada
ICC/IF image of ab26721 stained human HeLa cells. The cells were 4% PFA fixed (10 min), permabilised in 0.1% PBS-Tween (20 min) and incubated with the antibody (ab26721, 1µg/ml) for 1h at room temperature. 1%BSA / 10% normal goat serum / 0.3M glycine was used to block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue). This antibody also gave a positive IF result in HEK 293, HepG2 and MCF7 cells.
All lanes : Anti-RNA polymerase II CTD repeat YSPTSPS antibody - ChIP Grade (ab26721) at 1 µg/ml
Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lane 3 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with
Lane 4 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with
Lane 5 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with
Lane 6 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with
Lane 7 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with
Lane 8 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with
Lysates/proteins at 20 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) (ab65484) at 1/3000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 220 kDa
Observed band size : 220 kDa
Exposure time : 1 minute
3
Call 01223 696 000 or contact us